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ing will feature current information on uremia and the In the article cited above, on page 1091, Table 3 should
cardiovascular system. The deadline for abstract submis- read as follows:
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For further information, contact: Professor Christoph
Table 3. Effect of human serum albumin (HSA) on
lysophosphatidylcholine (LPC)-mediated inhibition
of acetylcholine (1 mol/L)-mediated relaxation after
Wanner, Department of Medicine, Division of Nephrol- phenylephrine contraction, after a 90-minute incubation period
ogy, University of Wu¨rzburg, Josef-Schneider Str. 2,
HSA
D-97080 Wu¨rzburg, Germany. Fax: 49 932 201 3502;
50 g/L 20 g/L 6 g/L 0 g/LE-mail: c.wanner@medizin.uni-wuerzburg.de
0 mol/L LPC 616 685 625 654
100 mol/L LPC 641 638 626 11d
200 mol/L LPC 554 634 444c 00dAWARDS AND GRANTS 400 mol/L LPC 593 605 72c ND
600 mol/L LPC 586 547 11c NDThe National Kidney Foundation (NKF) is inviting
800 mol/L LPC 242a 54b ND ND
applications for its research grants and training awards. 1000 mol/L LPC 236a 00b 00c ND
1400 mol/L LPC 144a ND ND NDFellowship candidates must apply by November 1, 2001,
2000 mol/L LPC 149a 00b ND NDfor funding effective July 1, 2002. Applications for Young
Data are expressed as percentage relaxation. ND is not determined.Investigator Grants ($50,000 per year for two years),
aP  0.05 vs. 0 mol/L LPC (50 g/L HSA)
Clinical Scientist Awards ($50,000 per year for three bP  0.05 vs. 0 mol/L LPC (20 g/L HSA)
cP  0.05 vs. 0 mol/L LPC (6 g/L HSA)years), and all other mechanisms for support must submit dP  0.05 vs. 0 mol/L LPC (0 g/L HSA)
proposals by February 1, 2002, for funding that will be
The authors and the Editor apologize for the error.available on July 1, 2002. Applications will be available
